Periodic Reporting for period 1 - NeutrAD (Targetting neutrophil-mediated neurotoxicity for the treatment of Alzheimer's Disease)

Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 35 million people worldwide, and its prevalence is projected to nearly double every 20 years with tremendous social and economic impact on society. The central neuropathological characteristics...